Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?

December 2018

Attorney Explains Risks from New ‘Support Act’

Laboratory Compliance / By

CEO SUMMARY: Legislation signed into law on Oct. 24 was designed to stem the nation’s opioid crisis. But in addition to applying to sober homes and addiction treatment centers, the law also applies to clinical laboratories. Called the ‘Support for Patients and Communities Act,’ the law could authorize criminal penalties for labs that pay sales …

Attorney Explains Risks from New ‘Support Act’ Read More »

To access this post, you must purchase The Dark Report.

U of Florida Health Improves Patient Care with PGx Testing

Genetic Testing / By

CEO SUMMARY: Since 2011, the University of Florida Health System has used pharmacogenetic test (PGx) results to guide physicians when they prescribe certain drugs. This initiative has improved patient outcomes, reduced the overall cost per episode of care, and gained partial reimbursement from health insurers for PGx test claims. As this testing becomes more widespread, clinical …

U of Florida Health Improves Patient Care with PGx Testing Read More »

To access this post, you must purchase The Dark Report.

UnitedHealth Rumored to Be Excluding Labs from Its Network

Clinical Laboratory / By

IN RECENT DAYS, RUMORS HAVE SURFACED that UnitedHealthcare has begun to terminate the contracts it holds with a number of regional and non-national clinical laboratories. This news surfaced just as The Dark Report went to press. Given its importance to the clinical laboratory industry, we wanted to alert lab executives and pathologists to this development …

UnitedHealth Rumored to Be Excluding Labs from Its Network Read More »

To access this post, you must purchase The Dark Report.

Illumina to Pay $1.2 Billion to Acquire Pacific Biosciences

Laboratory Management / By

IT’S AN ACQUISITION THAT BRINGS TOGETHER two different gene sequencing technologies into one firm. On Nov. 1, Illumina, Inc., announced an agreement to acquire Pacific Biosciences (PacBio) for $1.2 billion. This deal will bolster Illumina’s already-dominant position in the market for DNA-sequencing machines. Wall Street analysts quickly pointed out that this gives Illumina control of two …

Illumina to Pay $1.2 Billion to Acquire Pacific Biosciences Read More »

To access this post, you must purchase The Dark Report.

December 3, 2018 Intelligence: Late Breaking Lab News

Late Breaking Lab News / By

Another long-established regional laboratory company is about to be acquired. On November 27, Boyce and Bynum Pathology Laboratories of Columbia, Mo., disclosed that it had entered an agreement to be acquired by Quest Diagnostics Inc. Notably, the press release about the agreement states that the anatomic pathology division, Boyce and Bynum Professional Services, Inc., and the …

December 3, 2018 Intelligence: Late Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

New Opioid Law Goes Beyond – Far Beyond – Anti-Kickback Statute

TDR Insider / By

CEO SUMMARY: At the last minute, Congress added all clinical laboratories to a far-reaching provision in the newly-enacted Support for Patients and Communities Act. Unlike the Anti-Kickback Statute, this provision applies to all payers, both government and private, and offers no safe harbors. Lab experts say this new law could turn relatively innocuous and heretofore …

New Opioid Law Goes Beyond – Far Beyond – Anti-Kickback Statute Read More »

To access this post, you must purchase The Dark Report.

Facebook-f Twitter Linkedin-in

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com

© 2024 The Dark Report. All rights reserved.

;